Ethics of Personalised Medicine: Importance of the Multidisciplinary Approach in KidneySign Project
PROTEOMICS · 2025
DOI: 10.1002/pmic.202400176 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2025. Verfasst von Delphine Azéma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire CERPOP, équipe BIOETHICS, UMR 1295, Centre d'Epidémiologie et de Recherche en santé des POPulations, Toulouse, France. Hauptthemen laut MEDLINE: Precision Medicine, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ANR, BMBF, BMG, FWF and Vinnova, under the frame of ERA-PerMed, European Cooperation in Science and Technology, COST Action PerMedik.
Themen: Ethik in der Pflege
Abstract (Originalsprache)
This article explores the ethical and societal issues in developing personalised medicine (PM) as part of the KidneySign project, which aims to mobilise translational big data to validate a proteomic signature of renal fibrosis with prognostic value. This research offers hope for improved management of chronic kidney disease, including diagnosis and treatment. This article examines how the human and social sciences can be mobilised within a biomedical research project to identify and prevent concomitant ethical, legal and social issues. This point of view defends a multidisciplinary approach to PM and artificial intelligence in medicine. Presenting theoretical and methodological contributions of social sciences in the case of KidneySign offers an opportunity to better understand the integration of these disciplines in biomedical research. It allows us to question the study protocol itself and to frame it through legal obligations, as well as potential legal consequences and challenges. Moreover, sociological assessments help identify key points and highlight the limits of the technophilic fantasy in the representations of patients and health professionals. The introduction of new technologies into medical research and practice requires special attention to ethics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratoire CERPOP, équipe BIOETHICS, UMR 1295, Centre d'Epidémiologie et de Recherche en santé des POPulations, Toulouse, France.
- RD Néphrologie SAS, Montpellier, France.
- Médecin néphrologue et directeur de recherche honoraire, RD Néphrologie SAS, Montpellier, France.
ORCID-Profile: Delphine Azéma, Flore Duranton
Förderung
- ANR, BMBF, BMG, FWF and Vinnova, under the frame of ERA-PerMed
- European Cooperation in Science and Technology
- COST Action PerMedik
Zitieren
APA
Azéma, D., Duranton, F., Argilés, À., & Rial-Sebbag, E. (2025). Ethics of Personalised Medicine: Importance of the Multidisciplinary Approach in KidneySign Project. PROTEOMICS. https://doi.org/10.1002/pmic.202400176
Vancouver
Azéma D, Duranton F, Argilés À, Rial-Sebbag E. Ethics of Personalised Medicine: Importance of the Multidisciplinary Approach in KidneySign Project. PROTEOMICS. 2025. doi:10.1002/pmic.202400176
BibTeX
@article{Azma2025,
author = {Azéma, Delphine and Duranton, Flore and Argilés, Àngel and Rial-Sebbag, Emmanuelle},
title = {Ethics of Personalised Medicine: Importance of the Multidisciplinary Approach in KidneySign Project},
journal = {PROTEOMICS},
year = {2025},
doi = {10.1002/pmic.202400176}
}
EUVIMED